- miR-9 is a tumor suppressor in pediatric AML with t(8;21)2014 | Second Faculty of Medicine
- The clinical relevance of BAALC and ERG expression levels in pediatric AML2013 | Second Faculty of Medicine
- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia2010 | Second Faculty of Medicine
- Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model2012 | Second Faculty of Medicine
- MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML2018 | Second Faculty of Medicine
- High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome2010 | Second Faculty of Medicine
- Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 20042017 | First Faculty of Medicine
- BCOR and BCORL1 mutations in pediatric acute myeloid leukemia2015 | Second Faculty of Medicine
- Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group2018 | Second Faculty of Medicine
- Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)2011 | Second Faculty of Medicine
- Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis2016 | Second Faculty of Medicine
- Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia2012 | Second Faculty of Medicine
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | Second Faculty of Medicine
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia2009 | Second Faculty of Medicine
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | First Faculty of Medicine
- Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study2022 | Publication without faculty affiliation
- MicroRNA-106b similar to 25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia2016 | Second Faculty of Medicine
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel2012 | Second Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | First Faculty of Medicine
- No Prognostic Impact of the WT1 Gene Single Nucleotide Polymorphism rs16754 in Pediatric Acute Myeloid Leukemia2010 | Second Faculty of Medicine
- High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia2012 | Second Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | Second Faculty of Medicine
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern2013 | Second Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | Second Faculty of Medicine